Hosted on MSN6d
Studies Point to Several Options for Ulcerative Colitis After Anti-TNF Failure
Clinical outcomes for ulcerative colitis patients with a prior anti-TNF therapy failure appeared similar with ustekinumab ...
Everyday Health13d
Ulcerative Colitis Diet: What to Eat and Avoid, 7-Day Meal Plan, More
Low-fiber fruits and vegetables, lean proteins, and foods rich in omega-3 fatty acids tend to be easier on an inflamed gut, ...
Can AI Unlock New Treatment Possibilities For Inflammatory Bowel Disease? How Johnson & Johnson Is Leading The Way
Johnson & Johnson, a leader in immunology, has developed ARGES, a new AI-powered tool that could transform endoscopic ...
Business Wire1d
Thetis Pharmaceuticals Presents New Preclinical and Clinical Data for TP-317 at ECCO 2025
Thetis Pharmaceuticals LLC (“Thetis”), a clinical-stage company developing TP-317, a first-in-class, small molecule drug ...
Crain's Cleveland Business1d
Larry Sears, Sally Zlotnick Sears make ‘transformative’ gift to Crohn’s & Colitis Foundation
Local philanthropists Larry Sears and Sally Zlotnick Sears awarded a “transformative” $1 million gift to the Crohn’s & ...
Man from Staten Island who suffered with undiagnosed Crohn’s disease has a message for people feeling ill: Advocate for yourself
It basically kept getting passed off as, like, anxiety or stress since I was meeting someone new and eating new foods...” ...
Spyre Therapeutics Announces Poster Presentation at the 20th Congress of the European Crohn's and Colitis Organisation
Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the "Company" or "Spyre"), a clinical-stage biotechnology company advancing best-in-class antibody engineering, dose optimization, and rational therapeutic ...
Amneal launches Mesalamine; receives U.S. FDA Lenalidomide approval
Amneal Pharmaceuticals (AMRX) announced the launch of mesalamine 800 mg delayed-release tablets, an aminosalicylate indicated for the treatment ...